Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective
- PMID: 33033166
- PMCID: PMC7656153
- DOI: 10.1136/ijgc-2020-001975
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective
Abstract
Background: On March 16, 2020, the federal government of Austria declared a nationwide lockdown due to the COVID-19 pandemic. Since the lockdown, screening examinations and routine checkups have been restricted to prevent the spread of the virus and to increase the hospitals' bed capacity across the country. This resulted in a severe decline of patient referrals to the hospitals.
Objective: To assess the impact of the COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers in Austria.
Methods: Data of 2077 patients from 18 centers in Austria with newly diagnosed gynecological or breast cancer between January and May 2019 and January and May 2020 were collected. Clinical parameters, including symptoms, performance status, co-morbidities, and referral status, were compared between the time before and after the COVID-19 outbreak.
Results: Our results showed a slight increase of newly diagnosed cancers in January and February 2020 as compared with 2019 (+2 and +35%, respectively) and a strong decline in newly diagnosed tumors since the lockdown: -24% in March 2020 versus March 2019, -49% in April 2020 versus April 2019, -49% in May 2020 versus May 2019. Two-thirds of patients diagnosed during the pandemic presented with tumor-specific symptoms compared with less than 50% before the pandemic (p<0.001). Moreover, almost 50% of patients in 2020 had no co-morbidities compared with 35% in 2019 (p<0.001). Patients, who already had a malignant disease, were rarely diagnosed with a new cancer in 2020 as compared with 2019 (11% vs 6%; p<0.001).
Conclusions: The lockdown led to a decreased number of newly diagnosed gynecological and breast cancers. The decreased accessibility of the medical services and postponed diagnosis of potentially curable cancers during the COVID-19 pandemic may be a step backwards in our healthcare system and might impair cancer treatment outcomes. Therefore, new strategies to manage early cancer detection are needed to optimize cancer care in a time of pandemic in the future.
Keywords: neoplasms.
© IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective.Arch Gynecol Obstet. 2022 Apr;305(4):945-953. doi: 10.1007/s00404-021-06259-5. Epub 2021 Sep 24. Arch Gynecol Obstet. 2022. PMID: 34559295 Free PMC article.
-
[Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].Gynecol Obstet Fertil Senol. 2020 Nov;48(11):777-783. doi: 10.1016/j.gofs.2020.09.011. Epub 2020 Sep 30. Gynecol Obstet Fertil Senol. 2020. PMID: 33010487 Free PMC article. French.
-
Impact of the COVID-19 Pandemic on Diagnosis and Management of Gynecological Cancer: A Single-Center Analysis.Medicina (Kaunas). 2022 Dec 16;58(12):1862. doi: 10.3390/medicina58121862. Medicina (Kaunas). 2022. PMID: 36557063 Free PMC article.
-
Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.J Gynecol Oncol. 2020 Jul;31(4):e68. doi: 10.3802/jgo.2020.31.e68. Epub 2020 May 27. J Gynecol Oncol. 2020. PMID: 32458596 Free PMC article. Review.
-
ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies.ESMO Open. 2020 Jul;5(Suppl 3):e000827. doi: 10.1136/esmoopen-2020-000827. ESMO Open. 2020. PMID: 32718919 Free PMC article. Review.
Cited by
-
Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England.J Cancer Policy. 2022 Mar;31:100316. doi: 10.1016/j.jcpo.2021.100316. Epub 2021 Dec 8. J Cancer Policy. 2022. PMID: 35559868 Free PMC article.
-
The Spill-Over Impact of the Novel Coronavirus-19 Pandemic on Medical Care and Disease Outcomes in Non-communicable Diseases: A Narrative Review.Public Health Rev. 2022 Apr 27;43:1604121. doi: 10.3389/phrs.2022.1604121. eCollection 2022. Public Health Rev. 2022. PMID: 35574567 Free PMC article. Review.
-
Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.Medicina (Kaunas). 2024 May 30;60(6):909. doi: 10.3390/medicina60060909. Medicina (Kaunas). 2024. PMID: 38929526 Free PMC article.
-
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany.Arch Gynecol Obstet. 2022 Mar;305(3):713-718. doi: 10.1007/s00404-021-06211-7. Epub 2021 Sep 7. Arch Gynecol Obstet. 2022. PMID: 34491417 Free PMC article.
-
US Cancer Screening Recommendations: Developments and the Impact of COVID-19.Med Sci (Basel). 2022 Mar 1;10(1):16. doi: 10.3390/medsci10010016. Med Sci (Basel). 2022. PMID: 35323215 Free PMC article. Review.
References
-
- John Hopkins University and Medicine COVID-19 Map - Johns Hopkins Coronavirus Resource Center, 2020. Available: https://coronavirus.jhu.edu/map.html [Accessed 7 Sep 2020].
-
- Federal Ministry of Social Affairs, H., Care and Consumer Protection, Republic of Austria "Official COVID19 Dashboard (Public Information): Hospitalisation.", 2020. Available: https://info.gesundheitsministerium.at/dashboard_Hosp.html?l=de
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous